Hipp Health | $6,200,000 | (Oct 8, 2025)
Cyberwave | $8,129,205 | (Oct 8, 2025)
Oath Surgical | $24,000,000 | (Oct 8, 2025)
Certified by Founder
Lodge
Delphia Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/05/2024
- Series A
- $67,000,000
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.
- Industry Biotechnology Research
- Website https://www.delphiatx.com/
- LinkedIn https://www.linkedin.com/company/delphia-therapeutics/
Attuned Intelligence | $13,000,000 | (Oct 8, 2025)
Energy Robotics | $13,500,000 | (Oct 8, 2025)
Increase Alpha | $3,500,000 | (Oct 8, 2025)
Dragonfly(UK) | $3,486,352 | (Oct 8, 2025)
Appy.AI | $5,000,000 | (Oct 8, 2025)
Tycho.AI | $10,000,000 | (Oct 8, 2025)
Zingage | $12,500,000 | (Oct 8, 2025)
Peer AI | $12,100,000 | (Oct 8, 2025)
Kadence | $20,000,000 | (Oct 8, 2025)